A Pilot Study of CYP2D6 Screening for Adverse Drug Reactions to Hydrocodone in Breast Milk
David Haas, MD
Primary Investigator
Jessica MacLean
Primary Investigator
Overview
The purpose of this study is to see if differences in your DNA (the blueprints or genetic material in your body) may play a role in how well pain medication works for you after surgery and if it plays a role in your baby?s behaviors when breast feeding
Description
This is a prospective pilot study in 100 consenting women. All women will be consented prior to non-emergent cesarean section. The women and their infants will undergo noninvasive genetic testing for drug metabolizing enzyme pathway genotypes. This is a n
Eligibility
You may be eligible for this study if you meet the following criteria:
-
Conditions:
Drug Reactions
-
Age: Between 18 Years - 100 Years
-
Gender: Female